The co-hosts of HomeTalk USA’s “Made in America” segment, Michael King and Greg Owen, discuss President Trump’s attempt to level the playing field among the countries and try to rectify the inequities that have arisen over the years between America and its trading partners.

In addition, Greg Owen interviews Rosemary Gibson, author of the book “China Rx: Exposing the Risks of America’s Dependence on China for Medicine“. Here’s what the book’s co-authors, Rosemary Gibson and Janardan Prasad Singh, have to say about this troublesome situation and issues discussed in their book:

If you take a prescription drug, over-the-counter medicine, or vitamin, this book is for you. It reveals a dramatic shift in where the medicines in your kitchen cabinet or desk at work are made. The mainstream media has virtually ignored this shift, and their silence has kept you in the dark.

Antibiotics, chemotherapies, antidepressants, HIV/AIDS drugs, medicines for Alzheimer’s and Parkinson’s diseases, and birth control pills made in China are now sold in the United States. People taking them don’t know it, and neither do the physicians who prescribe them.

We wrote this book because everyone affected by outsourcing decisions should be able to find out where his or her medicines come from, and if they are made to the highest standards.

This book scratches the surface of a multibillion-dollar marketplace remarkable for its lack of transparency. We were able to piece together information from federal government documents, industry press releases, media reports, and scientific articles. Many people we interviewed are employed in the industry or government, and others are retired. Some understandably wish to remain anonymous, so we use pseudonyms for them.

We wrote China Rx in the public interest, not for any special interest. It tells a human story of the impact of globalization and de facto deregulation of the safety and security of America’s medicines. We hope the book, with its landmark investigative research, increases public awareness about where America’s medicines come from and the risks.

China Rx raises more questions than it answers. We invite policy makers, public interest organizations, and journalists to build on this foundation and delve deeper into the vast array of topics that we have only touched upon.

When we mentioned to colleagues and friends that we were writing this book, one of the most frequent questions we heard was, “Why are we buying drugs from China? Can’t we make them here?” Others responded with resignation, saying, “Well, everything else comes from there.”

Many companies say they are trying to reduce their exposure to foreign sourcing but can’t find products made in the United States. We have been heartened by a small number of industry players who want to ensure the country has a basic level of manufacturing capacity to make essential medicines. Jobs will return, communities will be revitalized, doctors and the public will have greater confidence in medicines, and the nation’s security will be strengthened.

We hope China Rx stimulates public policies and private initiatives to achieve these noble aims. It won’t be easy, but with a spirit of optimism and determination, what seems impossible is possible. And it’s the right thing to do.

Rosemary Gibson
Janardan Prasad Singh

Hosted by Ausha. See ausha.co/privacy-policy for more information.